Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

35.75
Delayed Data
As of May 26
 +1.60 / +4.69%
Today’s Change
17.25
Today|||52-Week Range
36.05
+41.58%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close34.15
Today’s open34.35
Day’s range34.35 - 36.05
Volume821,965
Average volume (3 months)554,333
Market cap$1.8B
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)+528.57%
Earnings growth (this year)-37.05%
Earnings growth (next 5 years)+27.00%
Revenue growth (last year)+48.87%
P/E ratio19.1
Price/Sales6.07
Price/Book9.32

Competitors

 Today’s
change
Today’s
% change
PCRXPacira Pharmaceutica...-0.30-0.66%
CBMCambrex Corp0.000.00%
AERIAerie Pharmaceutical...+1.65+3.04%
TBPHTheravance Biopharma...+0.12+0.32%
Data as of 4:02pm ET, 05/26/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)$0.26
Annual revenue (last year)$215.0M
Annual profit (last year)$91.2M
Net profit margin42.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Secretary &
Director
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts